U.S. President Donald Trump speaks with Secretary of Defense Pete Hegseth at a cabinet meeting held at the White House in Washington, DC, on July 8, 2025.
Kevin Lamarque | Reuters
president Donald Trump On Tuesday, threats to impose up to 200% tariffs on drugs imported into the United States “soon”.
“They will meet tariffs at very high rates,” Trump said at a cabinet meeting.
But he suggested that those taxes would not take effect immediately, saying he would “give people about a year and a half.”
“We’re going to give them a while to bring their actions together,” Trump said.
The president repeatedly threatened tariff proposals, so there is no guarantee that he would set drug tariffs at this rate. After Trump’s comments, drug inventory remained largely unchanged.
His most important comment on drug-specific tariffs made by Trump since April, when his administration conducted a so-called Section 232 investigation into the products. The legal authority allows the Secretary of Commerce to investigate the impact of imports on national security.
The tariffs on these plans will deal a long-awaited blow to pharmaceutical companies, many of which have Push backward And warns that taxes can increase costs, Deter invest In the United States, and disrupting the drug supply chain, putting patients at risk. The industry is already browsing Trump’s consequences Drug Pricing Policypharmaceutical manufacturers believe that this threatens both their bottom line and their ability to invest in R&D.
Trump says tariffs will incentivize pharmaceutical companies to transfer manufacturing operations to the U.S. Yililai,,,,, Johnson and Johnson,,,,, Abbvie Others have invested more money in the United States after the domestic drug manufacturing industry has shrunk significantly over the past few decades.
The existence of major drug stocks has largely remained unchanged after Trump’s comments.
